Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DoCM: a database of curated mutations in cancer.

Literature DB >> 27684579

DoCM: a database of curated mutations in cancer.

Benjamin J Ainscough^1,2, Malachi Griffith^1,2,3, Adam C Coffman¹, Alex H Wagner^1,2, Jason Kunisaki¹, Mayank Nk Choudhary³, Joshua F McMichael¹, Robert S Fulton^1,2,3, Richard K Wilson^1,2,3,4, Obi L Griffith^1,2,3,4, Elaine R Mardis^1,2,3,4.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Biomarkers, Tumor

Year: 2016 PMID： 27684579 PMCID： PMC5317181 DOI： 10.1038/nmeth.4000

Source DB: PubMed Journal: Nat Methods ISSN： 1548-7091 Impact factor: 28.547

× No keyword cloud information.

6 in total

1. Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

Authors: Laura E MacConaill; Elizabeth Garcia; Priyanka Shivdasani; Matthew Ducar; Ravali Adusumilli; Marc Breneiser; Mark Byrne; Lawrence Chung; Jodie Conneely; Lauren Crosby; Levi A Garraway; Xin Gong; William C Hahn; Charlie Hatton; Philip W Kantoff; Michael Kluk; Frank Kuo; Yonghui Jia; Ruchi Joshi; Janina Longtine; Allison Manning; Emanuele Palescandolo; Nematullah Sharaf; Lynette Sholl; Paul van Hummelen; Jacqueline Wade; Bruce M Wollinson; Dimity Zepf; Barrett J Rollins; Neal I Lindeman
Journal: J Mol Diagn Date: 2014-08-23 Impact factor: 5.568

Review 2. Standardized decision support in next generation sequencing reports of somatic cancer variants.

Authors: Rodrigo Dienstmann; Fei Dong; Darrell Borger; Dora Dias-Santagata; Leif W Ellisen; Long P Le; A John Iafrate
Journal: Mol Oncol Date: 2014-04-04 Impact factor: 6.603

3. DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.

Authors: Paul Yeh; Heidi Chen; Jenny Andrews; Riyad Naser; William Pao; Leora Horn
Journal: Clin Cancer Res Date: 2013-01-23 Impact factor: 12.531

4. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data.

Authors: Junjun Zhang; Joachim Baran; A Cros; Jonathan M Guberman; Syed Haider; Jack Hsu; Yong Liang; Elena Rivkin; Jianxin Wang; Brett Whitty; Marie Wong-Erasmus; Long Yao; Arek Kasprzyk
Journal: Database (Oxford) Date: 2011-09-19 Impact factor: 3.451

5. COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors: Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal: Nucleic Acids Res Date: 2014-10-29 Impact factor: 16.971

6. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Authors: Eliezer M Van Allen; Nikhil Wagle; Petar Stojanov; Danielle L Perrin; Kristian Cibulskis; Sara Marlow; Judit Jane-Valbuena; Dennis C Friedrich; Gregory Kryukov; Scott L Carter; Aaron McKenna; Andrey Sivachenko; Mara Rosenberg; Adam Kiezun; Douglas Voet; Michael Lawrence; Lee T Lichtenstein; Jeff G Gentry; Franklin W Huang; Jennifer Fostel; Deborah Farlow; David Barbie; Leena Gandhi; Eric S Lander; Stacy W Gray; Steven Joffe; Pasi Janne; Judy Garber; Laura MacConaill; Neal Lindeman; Barrett Rollins; Philip Kantoff; Sheila A Fisher; Stacey Gabriel; Gad Getz; Levi A Garraway
Journal: Nat Med Date: 2014-05-18 Impact factor: 53.440

6 in total

45 in total

1. ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants.

Authors: Najmeh Alirezaie; Kristin D Kernohan; Taila Hartley; Jacek Majewski; Toby Dylan Hocking
Journal: Am J Hum Genet Date: 2018-09-13 Impact factor: 11.025

2. Integrating chromatin accessibility states in the design of targeted sequencing panels for liquid biopsy.

Authors: Pegah Taklifi; Fahimeh Palizban; Mahya Mehrmohamadi
Journal: Sci Rep Date: 2022-06-21 Impact factor: 4.996

Review 3. Precision Oncology: The Road Ahead.

Authors: Daniela Senft; Mark D M Leiserson; Eytan Ruppin; Ze'ev A Ronai
Journal: Trends Mol Med Date: 2017-09-05 Impact factor: 11.951

4. Knowledge bases and software support for variant interpretation in precision oncology.

Authors: Florian Borchert; Andreas Mock; Aurelie Tomczak; Jonas Hügel; Samer Alkarkoukly; Alexander Knurr; Anna-Lena Volckmar; Albrecht Stenzinger; Peter Schirmacher; Jürgen Debus; Dirk Jäger; Thomas Longerich; Stefan Fröhling; Roland Eils; Nina Bougatf; Ulrich Sax; Matthieu-P Schapranow
Journal: Brief Bioinform Date: 2021-11-05 Impact factor: 11.622

DoCM: a database of curated mutations in cancer.

1. Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

Review 2. Standardized decision support in next generation sequencing reports of somatic cancer variants.

3. DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.

4. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data.

5. COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

6. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

1. ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants.

2. Integrating chromatin accessibility states in the design of targeted sequencing panels for liquid biopsy.

Review 3. Precision Oncology: The Road Ahead.

4. Knowledge bases and software support for variant interpretation in precision oncology.

5. OncoGEMINI: software for investigating tumor variants from multiple biopsies with integrated cancer annotations.

6. BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery.

7. Towards precision medicine: discovering novel gynecological cancer biomarkers and pathways using linked data.

8. A domain damage index to prioritizing the pathogenicity of missense variants.

9. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.

10. Anaplastic thyroid cancer: genome-based search for new targeted therapy options.